Ignite Creation Date:
2024-05-05 @ 11:57 PM
Last Modification Date:
2024-10-26 @ 10:42 AM
Study NCT ID:
NCT01455389
Status:
TERMINATED
Last Update Posted:
2022-03-02
First Post:
2011-10-17
Brief Title:
TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer
Sponsor:
Organization:
Genprex Inc